Takeheart Health Check      

452 Puska P
Quoted in Medical Monitor 13 January 1999 page 16

453 N Engl J Med 1995; 333: 1308-12

454 1999 World Health Organisation - International Society of Hypertension Guidelines for the Management of Hypertension
Journal of Hypertension 1999; 17: 151-183

455 Ness AR, Powles JW,
Fruit and vegetables and cardiovascular disease: a review.
Int J Epidemiol 1997; 26: 1-13

456 Knutsson A, Hallquist J, Reuterwall C et al.
Shift work and myocardial infarction: a case-control study.
Occup Environ Med 1999; 56: 46-50

457 Muntwyler J, Hennekens CH, Buring JE, Gaziano JM.
Mortality and light to moderate alcohol consumption after myocardial infarction.
The Lancet 1998; 352: 1882-5

458 Michael Day
Pig cells keep cholesterol at bay
New Scientist 18/1/97 p19

459 British Heart Foundation
Antioxidants and coronary heart disease.
Factfile 2/97

460 Ornish D, Scherwitz LW, Billings JH, et al.
Intensive lifestyle changes for reversal of coronary heart disease.
JAMA 1998; 280: 2001-7

461 Lloyd-Jones DM, Martin DO, Larson MG, Levy D.
Accuracy of death certificates for coding coronary heart disease as the cause of death.
Ann Intern Med 1998; 129: 1020-6

462 Lewin R.
Ruling Passions
New Scientist 3 April 1999 pps 34-39

463 Lancet 1999; 353: 1541-3

464 American Journal of Epidemiology 1994; 140: 1003-1008

465 Department of Health
Smoking Kills: a white paper on tobacco
The Stationary Office 1999

466 Preventative Medicine 1999; 28: 260-263

467 Callum C.
The UK Smoking Epidemic: Deaths in 1995.
London: Health Education Authority, 1998.

468 Parrott S, Godfrey C, Raw M, West R, McNeill A.
Guidance for commissioners on the cost effectiveness of smoking cessation interventions.
Thorax 1998; 53 (suppl 5, part 2): S1-38.

469 Office for National Statistics, Social Survey Division.
Living in Britain. Results from the 1996 General Household Survey
London: HMSO, 1998.

470 Office for National Statistics, Social Survey Division.
Health in England 1995.
London: The Stationary Office, 1996.

471 Overweight, Obesity and Cardiovascular Disease.
The British Heart Foundation, Factfile 1999 07/99.

472 Sekikawa A, Kuller LH and Ravnskov U.
Why heart disease mortality is low in France
BMJ 1999; 319: 255-6

473 Dunn N, Faragher B et al.
Oral contraceptives and myocardial infarction: results of the MICA case-control study.
BMJ 1999; 318: 1579-84

474 Joint British recommendations on prevention of coronary heart disease in clinical practice.
Heart 1998; 80: 21-29

475 Heart, 1999; 82: 581-3

476 Protheroe D, et alia
Br Med J 1999; 319: 1015-16 and 1027-30

477 Godfrey C, Professor of Health Economics at the University of York, Quoted in the Times 26/11/99.

478 Rees A.
Hypercholesterolaemia: secondary prevention.
Prescribers' Journal 1999; 39: 212-219

479 Durrington P.
Hypercholesterolaemia: primary prevention.
Prescribers' Journal 1999; 39: 202-211

480 Bosley CM, Parry DT, Cochrane GM.
Patient compliance with inhaled medication.
Eur Respir J 1994; 7: 504-9

481 Heart Outcomes Prevention Evaluation Study (HOPE)
Vitamin E supplementation and cardiovascular events in high-risk patients.
N Engl J Med 2000; 342: 154-60

482 MONICA Study.
Lancet 2000; 355: 675-87, 688-700

483Law M
BMJ 2000; 320: 861-4

484 World Bank
World Development Report. Investing in Health.
Oxford: Oxford University Press, 1993

485 BMJ 11/3/2000 vol 320 No 7236

486 N Engl J Med 1999; 340: 685-91

487 Thompson DR, Doman GS, Hopkins A.
Cardiac Rehabilitation: guidelines and audit standards.
London College of Physicians, 1997

488 Horgan J, Bethell H, Carson P, Davidson C, Julian D, Mayou RA, Nagle RE.
British Cardiac Society: working party report on cardiac rehabilitation.
British Heart Journal 1992; 67: 412-418

489 Catherine De Angelis, Editor JAMA
Quoted in USA Today 1/11/2000

490 The Chief Medical Officers Update 28
November 2000

491 US Department of Health and Human Services.
Physical Activity and Health: A report of the Surgeon General, Atlanta, GA
US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 1996

492 Tobacco Control 2000; 9: 397-400

493 Wolf PA et al.
Cigarette smoking as a risk factor for stroke: the Framingham study
JAMA 1988; 259: 1025-29

494 Ewing JA
Detecting alcoholism, the CAGE questionnaire.
JAMA 1984; 253: 1905-1907

495 Wallis EJ, Ramsey LE, Haq IU, Ghahramani P, Jackson PR, Rowland-Yeo K, Yeo WW.
Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population.
BMJ 2000; 320: 671-6 (abstract) (full text)

496 Sanmuganathan PS, Ghahranani P, Jackson PR, Wallis EJ, Ramsey LE.
Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials.
Heart 2001; 85: 265-271

497 Pocock SJ, McCormack V, Gueyffier F, Boutitie F, Fagard RH, Boissel J
A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials
BMJ 2001; 323: 75-81

498 Hippisley-Cox J, Pringle M.
General practice workload implications of the National Service Framework for Coronary Heart Disease: cross sectional survey.
BMJ 2001; 323: 269-70

499 Nature 2001; 414: 863-4.

500 Montgomery SM, Ekbum A.
Smoking during pregnancy and diabetes mellitis in a British longitudinal birth cohort.
BMJ 2002; 324: 26-27.